PharmSource Coverage of ASCO 2017

by

Chicago hosted 30,000 American Society of Clinical Oncology (ASCO) conference visitors this weekend, including myself and fellow researcher Scotty Chung-Siu. You may have noticed the uptick in the PharmSource Lead Sheet recently, especially in Phase I & II studies. In fact, oncology leads hold 46% of this week’s PharmSource Lead Sheet, so be sure to check it out to find more information, including development phases, APIs, specific therapeutic areas if available, enrollment status, FDA & EMA designations, and much more.

Let us know if you’d like to see more about any upcoming conferences, or need help navigating through PharmSource tools. We always look forward to the opportunity to help you make the most out of your PharmSource subscription!

Related posts:
PMA Approvals for Medical Devices and Diagnostics
PharmSource Coverage of AACR 2017 Yields Valuable BD Info
Time to Hit the Road!

Mahdia is a Research Analyst at PharmSource. She earned a BS degree in biology from George Mason University, where she minored in business. Prior to this, she received a magna cum laude honors Associates of Sciences degree from Northern Virginia Community College. Mahdia is avidly interested in clinical research and science.

More posts by Mahdia Hashimy